- Home
- CLEU vs COEP Comparison
CLEU vs COEP Comparison
Compare CLEU & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLEU
- COEP
- Stock Information
- Founded
- CLEU 2011
- COEP 2017
- Country
- CLEU China
- COEP United States
- Employees
- CLEU N/A
- COEP N/A
- Industry
- CLEU Other Consumer Services
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLEU Real Estate
- COEP Health Care
- Exchange
- CLEU Nasdaq
- COEP Nasdaq
- Market Cap
- CLEU 29.3M
- COEP 32.4M
- IPO Year
- CLEU 2020
- COEP N/A
- Fundamental
- Price
- CLEU $0.09
- COEP $10.52
- Analyst Decision
- CLEU
- COEP
- Analyst Count
- CLEU 0
- COEP 0
- Target Price
- CLEU N/A
- COEP N/A
- AVG Volume (30 Days)
- CLEU 51.5M
- COEP 109.2K
- Earning Date
- CLEU 10-11-2024
- COEP 03-25-2025
- Dividend Yield
- CLEU N/A
- COEP N/A
- EPS Growth
- CLEU N/A
- COEP N/A
- EPS
- CLEU N/A
- COEP N/A
- Revenue
- CLEU $2,413,409.00
- COEP N/A
- Revenue This Year
- CLEU N/A
- COEP N/A
- Revenue Next Year
- CLEU N/A
- COEP N/A
- P/E Ratio
- CLEU N/A
- COEP N/A
- Revenue Growth
- CLEU N/A
- COEP N/A
- 52 Week Low
- CLEU $0.09
- COEP $2.31
- 52 Week High
- CLEU $7.90
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- CLEU 31.94
- COEP 48.65
- Support Level
- CLEU $0.09
- COEP $9.27
- Resistance Level
- CLEU $0.11
- COEP $12.95
- Average True Range (ATR)
- CLEU 0.02
- COEP 1.59
- MACD
- CLEU -0.10
- COEP -0.33
- Stochastic Oscillator
- CLEU 1.10
- COEP 38.56
About CLEU China Liberal Education Holdings Limited
China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.